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OligodendrocyteTubulin Polymerization Promoting Protein/p25 (TPPP/p25), a neomorphicmoonlighting protein displaying both
physiological and pathological functions, plays a crucial role in the differentiation of the zinc-rich oligodendro-
cytes, themajor constituent of myelin sheath; and it is enriched and co-localizes withα-synuclein in brain inclu-
sions hallmarking Parkinson's disease and other synucleinopathies. In this work we showed that the binding of
Zn2+ to TPPP/p25 promotes its dimerization resulting in increased tubulin polymerization promoting activity.
We also demonstrated that the Zn2+ increases the intracellular TPPP/p25 level resulting in amore decoratedmi-
crotubule network in CHO10 and CG-4 cells expressing TPPP/p25 ectopically and endogenously, respectively.
This stabilization effect is crucial for the differentiation and aggresome formation under physiological and path-
ological conditions, respectively. The Zn2+-mediated effectwas similar to that produced by treatment of the cells
withMG132, a proteasome inhibitor or Zn2+ plus MG132 as quantiﬁed by cellular ELISA. The enhancing effect of
zinc ion on the level of TPPP/p25was independent of the expression level of the protein produced by doxycycline
induction at different levels or inhibition of the protein synthesis by cycloheximide. Thus, we suggest that the
zinc as a speciﬁc divalent cation could be involved in the ﬁne-tuning of the physiological TPPP/p25 level
counteracting both the enrichment and the lack of this protein leading to distinct central nervous system
diseases.
© 2014 Published by Elsevier B.V.1. Introduction
Zinc is a ubiquitous and essential micronutrient for microorganisms,
plants, animals and humans and is intimately linked to health, well-
being as well as a number of disease states [1–5]. Zinc is involved in
an extraordinary range of biological functions and is essential for
growth, development and for a host of diseases, although its precise
role is not fully understood. The total intracellular Zn2+ concentration
in eukaryotic cells is approximately 200 μM, while its intracellular free
concentration is in the nanomolar range [6]. Inside the cells, most of
the divalent Zn2+ cation is bound to speciﬁc Zn2+ transporters and de-
livered to speciﬁc targets. Thus zinc transporters and zinc binding pro-
teins play crucial roles in zinc homeostasis and maintenance of a very
narrow range of intracellular free zinc concentration, which is optimal
for cellular functions [7–9]. A number of data have been reported
which indicate compartments in the tissues with accumulated zinc, Research Centre for Natural
yar tudósok körútja 2, H-1117,
zky), olah.judit@ttk.mta.hu
oadel90@gmail.com (A. Szabó),
(J. Ovádi).concentration, for example, in the myelin membrane [10,11] and the
synaptic vesicles of someneurons in the brain [12]where the Zn2+ con-
centration is about 50 μMand 1mM, respectively (for review see [3]). In
fact, the brain has the highest zinc concentration as compared to other
organs; Zn2+ can modulate the activity of neurotransmitter receptors
thus may play a potential neuromodulatory role [12]. In myelinating
oligodendrocytes, Zn2+-myelin basic protein and Zn2+-proteolipid pro-
tein complexes are reported to be essential formaintaining the integrity
of the myelin sheath [13–15]. In animals, zinc-deﬁciency results in loss
of compact myelin [16,17]. The excessive Zn2+ release plays a key role
in inducing neuronal death during central nervous system (CNS) injury.
Dyshomeostasis of zinc ions has been observed in the case of different
neurodegenerative diseases such as Alzheimer's and Parkinson's dis-
eases; moreover, zinc ions accelerate the aggregation/ﬁbrillization of
alpha-synuclein, hallmark protein of Parkinson's disease [18,19].
Tubulin Polymerization Promoting Protein/p25 (TPPP/p25) modu-
lates the dynamics and stability of the microtubule system [20] and
plays a crucial role in the differentiation of the oligodendrocytes thus
likely in the ensheathment of axons as well [21,22]. TPPP/p25 does
not have awell-deﬁned 3D structure; it is an intrinsically disordered pro-
tein that is involved in the etiology of distinct CNS diseases such asmul-
tiple sclerosis, oligodendroglioma and synucleinopathies [23–25]. TPPP/
p25 is a prototype of neomorphic moonlighting proteins which display
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distinct protein partners [26]. TPPP/p25 occurs both in monomeric
and homodimeric forms; the dimer has been found to bemore compact
as expected from the assembly of the highly disorderedmonomers [27].
The protein has a zinc ﬁnger motif (His2Cys2) (His61–Cys83) within its
ﬂexible core regionwhich is straddled by extended unstructuredN- and
C-terminal segments [28,29]. The binding of Zn2+ to TPPP/p25 induces
molten globule formation, but not a well-deﬁned tertiary structure [29].
The afﬁnity constant of zinc binding to TPPP/p25 was evaluated from
isothermal titration calorimetry, Ka = (3.29 ± 0.64) × 104 M−1 [29].
Zn2+ of the divalent cations can uniquely inﬂuence the physiologically
relevant functions of TPPP/p25 such as its tubulin polymerization pro-
moting and GTPase activities.
In this work we showed that the enhanced tubulin polymerization
promoting activity of TPPP/p25 in the presence of zinc is resulted from
the oligomerization of the monomeric TPPP/p25. In CHO10 and CG-4
cells treated with additional Zn2+ the TPPP/p25 level signiﬁcantly in-
creased primarily due to the zinc-mediated stabilization against the
degradation of the protein by the proteasome system. The effect of
zinc on TPPP/p25 level was similar at different intracellular milieu pro-
duced by inhibition of either protein synthesis or the proteasome
machinery.2. Materials and methods
2.1. Protein puriﬁcation
The coding sequence of TPPP/p25was obtained by polymerase chain
reaction using the pEGFP-TPPP/p25 plasmid [30] as template and the
primers 5′-ATACATATGGCTGACAAGG-3′ and 5′-GATAAGCTTCTACTTG
CCCCCTTG-3′. The polymerase chain reaction fragment was digested
with NdeI and HindIII and cloned between the appropriate restriction
sites of the pT7-7 vector (Stanley Tabor, Harvard Medical School, Bos-
ton, Massachusetts; [31]; http://www.currentprotocols.com/WileyCDA/
CPUnit/refId-mb1602.html), resulting in the pT7-7-TPPP/p25 plasmid.
The protein was expressed in Escherichia coli, and then the cells were
centrifuged at 2500 g at 4 °C for 20 min. Next the cells were suspended
in 10 mM phosphate buffer pH 7.0 containing 200 mMNaCl and pro-
tease inhibitors (1 μg/mL leupeptin, 1 μg/mL pepstatin, 10 μM 4-(2-
aminoethyl) benzenesulfonyl ﬂuoride and 1 mM benzamidine).
After sonication and further centrifugation at 50,000 g at 4 °C for
25 min, the extract was dialyzed against buffer A (10 mM phosphate,
pH 7.0), then chromatographed on SP Sephadex ion-exchange col-
umn with a linear NaCl gradient from 0 to 1 M in buffer A. TPPP/
p25 eluted at 0.3 M NaCl, it was dialyzed against 50 mM ammonium
acetate and lyophilized. Purity of prepared TPPP/p25 was checked by
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE).
Monoclonal anti-TPPP/p25 antibody (mAb clone No. 6/C10) was la-
beled with (+)-Biotin-N-hydroxysuccinimide ester (NHS-D-Biotin,
Sigma H1759) according to the manufacturer's instructions and [32].
Brieﬂy, the Protein G afﬁnity puriﬁed antibody was dialyzed against
0.1 M sodium carbonate buffer pH 8.4 containing 0.1% NaN3 at 4 °C.
After dialysis, the protein concentration was adjusted to 20 mg/mL.
The NHS-D-Biotin was dissolved in dimethyl sulfoxide immediately
prior to use (solution was protected from light) at a concentration of
22 mg/mL. Using a volume equal to 10% of the total volume of the
immunoglobulin solution, the NHS-D-Biotinwas added to the immuno-
globulin solution with gentle stirring, and incubated at room tempera-
ture for 4 h. Finally the reaction solution was dialyzed against several
changes of phosphate buffered saline (PBS) buffer (0.01 M sodium
phosphate, 0.15 M sodium chloride, pH 7.4) containing 0.1% NaN3 at
4 °C.
Tubulin was puriﬁed from bovine brain by the method of Na and
Timasheff [33].2.2. Fluorescence spectroscopy
A 10 mM stock solution of N-(6-methoxy-8-quinolyl)-p-toluene-
sulfonamide (TSQ) (Invitrogen) was prepared in dimethyl sulfoxide.
The spectrum of 20 μM TSQ without or with 5 μM ΖnCl2 and 5 μM
TPPP/p25 was measured at room temperature in PBS buffer, pH 7.2. A
ΜnCl2 solution of 5 μMwas added to the TSQ-ZnCl2-TPPP/p25 sample,
where indicated. The ﬂuorescence spectra were recorded in quartz
cuvettes of 1 cm optical path length at 25 °C by a FluoroMax-3 spectro-
ﬂuorometer (Jobin Yvon Inc., Longiumeau, France). The excitation
wavelength was 360 nm (slit width 4 nm); emission spectra were col-
lected from 400 to 600 nm (slit width 4 nm). Data were processed
using DataMax software. Scanning was repeated three times, and the
spectra were averaged.
2.3. Turbidity measurements
The assembly of 7 μM tubulin was assessed in polymerization buffer
(50 mM 2-(N-morpholino)ethanesulfonic acid buffer) pH 6.6 contain-
ing 100 mM KCl, 1 mM dithioerythritol (DTE), 1 mMMgCl2 and 1 mM
ethylene glycol tetraacetic acid) at 37 °C. The polymerization of tubulin
was induced by addition of 3 μM TPPP/p25 in the absence and presence
of 100 μM ΖnCl2. In one case a TPPP/p25 stock solution at ~100-fold
higher concentration (400 μM) as in the assay was added to the tubulin
diluted in the cuvette without or with ΖnCl2; in the other case TPPP/p25
was diluted into the cuvettewith orwithout ZnCl2, incubated for 10min
and the polymerization was initiated by stock solution of tubulin. The
turbidity was monitored at 350 nm by a Cary 100 spectrophotometer
(Varian, Walnut Creek, Australia).
2.4. Cell culture and manipulation
CHO10 cells originated from CHO Tet-On cell line were induced to
express human TPPP/p25 as described previously [34]. Cells were
grown on 12 mm diameter coverslips for microscopic analysis (1
× 104 cells) and on 24-well plates for immunoblotting (2.5 × 104
cells). For cellular enzyme-linked immunosorbent assay (cELISA), cells
were plated on 96-well plates and cultured overnightwith doxycycline,
as indicated.
In the experiments where indicated, a 10 μM solution of MG132
(Sigma) or ZnCl2 (Sigma) (from 10mMstock solution dissolved in ster-
ile ultrapure water) was added for 3 h, then 1 μM vinblastine (Sigma)
was added to the assay at the last hour of the induction period. In the
case of the inhibition of protein synthesis, 20 μg/mL cycloheximide
was added to the cells (3 h and 5 min incubation) 5 min before the ad-
dition of ZnCl2 and/or MG132, where indicated. The CG-4 cell line was
propagated in DMEM-N1 30% conditioned medium obtained by neuro-
blastoma cell line B104 as described previously [22,35]. For immunoﬂu-
orescence microscopy, 2 × 104 cells were plated onto poly-L-ornithine-
coated glass coverslips, and the cells were incubated for 3 h with 1 μM




Cells aftermanipulation on tissue culture platewere ﬁxed by ice cold
methanol for 10 min. Next the wells were rehydrated by PBS, and
blocked with 1 mg/mL bovine serum albumin (BSA) in PBS containing
0.1% Triton-X-100 for 1 h at room temperature. Then the plate was se-
quentially incubated with monoclonal anti-TPPP/p25 antibody
(1.5 μg/mL) [23] and with an anti-mouse IgG-peroxidase conjugate
(1:2500, Sigma) in PBS buffer containing 1 mg/mL BSA and 0.1%
Triton-X-100, and incubated for 1 h at room temperature (both in a vol-
ume of 50 μL). Following each incubation step the wells were washed
thrice with PBS for 5 min. The TPPP/p25 concentration was quantiﬁed
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concentration of 3.7 mMwith 0.03% peroxide as substrate. The reaction
was stopped after 15 min with 1 M H2SO4; absorbance was read at
490 nmwith an EnSpire Multimode Reader (Perkin Elmer).2.5.2. Sandwich ELISA
The plate was coated with 1 μg/mL (50 μL/well) monoclonal anti-
TPPP/p25 antibody [23] in 200 mM Na2CO3 buffer pH 9.6 overnight at
4 °C. The wells were blocked with 1 mg/mL BSA in PBS for 1 h at room
temperature. Next, the plate was incubated with serial dilutions of
5 μM TPPP/p25 for 1 h at room temperature in PBS. Where indicated,
TPPP/p25 was pre-incubated with 2 or 10 μM divalent metal ions and/
or 100 μMDTE for 30 min at room temperature. Then the plate was se-
quentially incubated with biotinylated monoclonal anti-TPPP/p25 anti-
body (1 μg/mL) and peroxidase conjugated avidin (Calbiochem)
(2.5 μg/mL). Both antibodies were in PBS buffer containing 1 mg/mL
BSA, and incubated for 1 h at room temperature. Between each incuba-
tion step the wells were washed thrice with PBS containing 0.05%Fig. 1. Zinc binding to TPPP/p25 and dimerization-dependent effect of zinc on TPPP/p25-induce
wavelength was 360 nm; emission spectra were recorded at room temperature in PBS buffer. 2
line). The spectrum of TPPP/p25 (dotted line) and the effect of 5 μMΜnCl2 (dash-dot-dotted l
mentswere recorded. Representative spectra are shown; error of determinations (SEM) is±10%
a stock solution (400 μM) in the absence (bold line) or presence (dashed line) of ΖnCl2; or TP
(dotted line) of ΖnCl2, then the reaction was initiated by addition of tubulin from a stock soluti
of zinc, tubulin and TPPP/p25 were 100 μM, 7 μM and 3 μM, respectively. Three independent ex
tions (SEM) is ±10%. C and D: Sandwich ELISA. Effects of divalent metal ions on the monomer-dim
immobilized on the plate, and TPPP/p25 at different concentrations was added onto the plate w
incubatedwith or without 100 μMDTE for 30min at room temperature. Then the samemonocl
peroxidase conjugated avidin reaction. C: The effect of incubation and/ormetal ions on TPPP/p2
difference between samples and the control at the same TPPP/p25 concentration (according to
DTE (○, solid line), in the presence of 2 μM ZnCl2 without (▲, dashed line) or with incubation
(SEM) (n= 3) (C, D).Tween 20 for 10 min. The presence of antibodies was detected using
o-phenylenediamine as described at the cELISA section.
2.6. Immunocytochemistry
CHO10 cells were ﬁxed with ice-cold methanol for 10 min. After
washes in PBS, samples were blocked for 30 min in PBS-0.1% Triton
X-100 (TPB) containing 5% fetal calf serum (TPB-FCS). Subsequently,
the cells were stained with a monoclonal anti-TPPP/p25 antibody
(1 μg/mL) [23] followed by Alexa 546 conjugated anti-mouse antibody
(2 μg/mL) (Invitrogen). The samples were washed three times with
PBS after antibody incubation. Nuclei were counterstained with 4,6-
diamidino-2-phenylindole (DAPI). CG-4 cells were ﬁxed and blocked
similarly as in the case of CHO10 cells. Subsequently, the cells were
stained with a monoclonal antibody against α-tubulin (clone DM1A,
Sigma) (1 μg/mL) and a polyclonal rat serum against TPPP/p25
(1:1000) [25] followed by Alexa 488 and Alexa 546 conjugated anti-
mouse (1 μg/mL) and anti-rat (1 μg/mL) antibodies, respectively (both
from Invitrogen and cross-absorbed). Images of cell samples wered tubulin assembly. A: Fluorescence spectroscopy using TSQ as speciﬁc zinc sensor. Excitation
0 μM TSQ without (solid line) or with 5 μM ΖnCl2 (bold line) and 5 μM TPPP/p25 (dashed
ine) on the TSQ-ZnCl2-TPPP/p25 complex are also shown. Three-ﬁve independent experi-
. B: Turbidimetry. The polymerization of tubulinwas induced by addition of TPPP/p25 from
PP/p25 was diluted and incubated in the cuvette in the absence (solid line) and presence
on (280 μM) in polymerization buffer. In both sets of experiments the ﬁnal concentrations
periments were performed. Representative polymerization is shown; error of determina-
er equilibrium of TPPP/p25 at different conditions. Monoclonal anti-TPPP/p25 antibody was
ithout or with divalent cations (2 or 10 μM). In the case of incubation, TPPP/p25 was pre-
onal anti-TPPP/p25 antibodywas added in biotinylated form, whichwas detected through
5 at 1.25 (black column) or 0.3125 (white column) μMprotein concentration. * Signiﬁcant
the Student's t-test, p b 0.05). D: TPPP/p25 without (●, bold line) or with incubation with
with DTE (△, dotted line). Error bars represent the standard error of the determinations
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microscope.
2.7. Immunoblotting
For detection of TPPP/p25 level in cellular samples, wells were
washed with PBS; next the cells were lysed in 150 μL RIPA buffer
containing protein inhibitor mix (Sigma). Samples were centrifuged at
10,000 g at 4 °C for 10 min and the supernatants were stored at
−70 °C. The protein concentration of samples was measured by the
Bradford method [36] using the Bio-Rad protein assay kit. 10 μg of
extracts was analyzed by SDS-PAGE and immunoblotting onto
polyvinylidene diﬂuoride membrane using a polyclonal rat serum
against TPPP/p25 (1:5000) [25] and a monoclonal antibody against
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (1 μg/mL)
(CB1001, 6C5, Calbiochem), followed by an anti-rat and anti-mouse
IgG-peroxidase conjugate, respectively (both 1:5000, Sigma).
3. Results
3.1. Speciﬁc binding of zinc to TPPP/p25
A commonly used ﬂuorophore, TSQ, forms a 2:1 complex with Zn2+
in a reaction that results in a dramatic increase of theﬂuorescence emis-
sion spectrum accompanied by a shift of themaximum; it also can form
a ternary TSQ–zinc–protein complex with different emissionmaximum
[37]. TSQ is used as a zinc-speciﬁcﬂuorescent chelator in spite of the fact
that it chelates a variety of transition metal cations with varying afﬁni-
ties; however, it ﬂuoresces strongly in complex with zinc and only
weakly with othermetals of atomic radii similar to zinc. In order to con-
ﬁrm the direct and speciﬁc binding of Zn2+ to TPPP/p25 ﬂuorescence
spectroscopic studies were carried out with TSQ sensor. As shown in
Fig. 1A, TPPP/p25 increased the ﬂuorescence intensity of the TSQ–zinc
complex coupled with a blue-shift indicating the binding of zinc com-
plex to TPPP/p25. This ﬁnding supports our previous data obtained
with 8-anilinonaphthalene-1-sulfonic acid [29]. Now the speciﬁcity of
the zinc binding was tested by using manganese, another divalent cat-
ion, which did not affect the spectrum.
3.2. Zinc-induced functional changes of TPPP/p25
Previously we reported that the zinc-induced structural alteration
affected the tubulin polymerization promoting activity of TPPP/p25
[29]. Later on, we have also demonstrated by size exclusion gelFig. 2.Global overviewof intracellular TPPP/p25 level (red) in the CHO10 cell populations visual
TPPP/p25 expression was induced by 100 ng/mL doxycycline (overnight), then the cells were
125 μm.chromatography that TPPP/p25 displays concentration-dependent di-
merization which affects its tubulin polymerization promoting activi-
ty [27]; however, the relationship of these processes was not studied.
Here we analyzed the functional consequences of zinc binding to
TPPP/p25 bymeans of turbidity assay at different pre-incubation condi-
tions: i) TPPP/p25 solution was added to the tubulin diluted in the cu-
vette with or without zinc; ii) the cuvette contained the diluted TPPP/
p25 with or without zinc, and the reaction was initiated by tubulin
from a stock solution. At all these conditions the concentrations of tubu-
lin, TPPP/p25 and ZnCl2 were identical in all turbidity assays. We dem-
onstrated earlier that the zinc cation did not inﬂuence tubulin
polymerization in the absence of TPPP/p25 when polymerization was
induced by paclitaxel or TPPP3/p20, a TPPP/p25 homologue without
zinc ﬁnger motif [29].
As illustrated in Fig. 1B, the potency of TPPP/p25 to promote tubulin
polymerization was much higher when the polymerization was initiat-
ed by TPPP/p25 from the stock solution than by tubulin (when TPPP/
p25 was diluted) as expected [27]. The addition of zinc counteracted
the dilution-mediated reduction of its tubulin polymerization activity.
This ﬁnding shows that the TPPP/p25 species mediating tubulin assem-
bly is activated by the addition of zinc. Since the result of the control ex-
periment (no zinc) suggested that the dimer enriched TPPP/p25 sample
displayed much higher polymerization activity, it is likely that the zinc
favors the dimerization of TPPP/p25.
3.3. Zinc-induced dimerization of TPPP/p25
To obtain evidence on the role of zinc in the dimerization of TPPP/
p25, sandwich ELISA experiment was performed. The rational of
this study was as follows. Monoclonal anti-TPPP/p25 antibody was
immobilized on the plate, and TPPP/p25 pre-incubated or not with
ZnCl2 was diluted onto the plate. Then the same monoclonal anti-
TPPP/p25 antibody in biotinylated form was added onto the plate,
the binding of which to the dimeric TPPP/p25 could be detected
through peroxidase conjugated avidin reaction. This sandwich
ELISA arrangement ensured the exclusive detection of the dimer/
oligomer TPPP/p25 species since monomers cannot bind simulta-
neously to the immobilized and the biotinylated antibodies with
the same epitope as was demonstrated for alpha-synuclein [38]
and beta-amyloid systems [39] as well.
Serial dilution of TPPP/p25was added onto the platewithout orwith
ZnCl2. The 5 μM TPPP/p25 solutions were prepared at three different
manners: i) TPPP/p25 from a stock solution (400 μM) was diluted to
5 μM and added immediately onto the plate with or without ZnCl2 orized by confocal ﬂuorescencemicroscopy. Control (induced, no zinc) and zinc-treated cells.
treated with 10 μM Zn2+ for 3 h. Nuclei were counterstained with DAPI (blue). Scale bar:
Fig. 3. Effect of zinc and/or vinblastine (VBL) on the localization and level of TPPP/p25 in CHO10 cells. A: Confocal ﬂuorescence microscopic images using anti-TPPP/p25 antibody. Nuclei
were counterstainedwith DAPI (blue). Scale bar: 10 μm. B:Quantiﬁcation of the intracellular TPPP/p25 level in the absence (grey column) and presence (white column) of zinc and/or VBL
in CHO10 cells by cELISA. TPPP/p25 expression was induced by 100 ng/mL doxycycline (overnight), then the cells were treated with 10 μM Zn2+ and/or 1 μMVBL for 3 h. Error bars rep-
resent the standard error of the determinations (SEM) (n= 3). * Signiﬁcant difference between samples with and without the addition of zinc (according to Student's t-test, p b 0.05).
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iii) 5 μM TPPP/p25 incubated with or without ZnCl2 at room tempera-
ture for 30min in the presence of 100 μMDTEwere added to the plates.
The presence of Zn2+, but not that ofMnCl2, increased thebinding of the
biotinylated TPPP/p25 antibody indicating the elevation of the amount
of dimeric/oligomeric forms (Fig. 1C and D). The effect was more pro-
nounced at 10 μM as compared to that at 2 μM Zn2+. This ﬁnding
shows the speciﬁc effect of the zinc on the oligomerization of TPPP/
p25. The dilution of TPPP/p25 followed by 30 min incubation reduced
the amount of dimeric (oligomeric) forms in the diluted sample
(Fig. 1C). This effect was more pronounced in the presence of DTE
when the oligomers were not stabilized by intermolecular S–S bridges
(Fig. 1C and D). In fact, the presence of DTE diminished the disulﬁde
bridges formed by spontaneous oxidation during the incubation atFig. 4. The effect of zinc on the intracellular TPPP/p25 level in CHO10 cells at different TPPP/p25
cycline as described in Materials and methods. B: Effect of addition of 0 (black column), 5 (gre
determined after 3 h of incubation. Error bars represent the standard error of the determination
of zinc (according to Student's t-test, p b 0.05).room temperature as we described previously [27]. Consequently, in
the diluted protein sample the presence of DTE resulted in predomi-
nantly monomers which display no or very low binding afﬁnity. The
presence of zinc, however, counteracted this effect; this divalent metal
ion increased the amount of dimeric/oligomeric forms and diminished
the effect of dilution. These data show that, on one hand, a signiﬁcant
fraction of TPPP/p25 occurs in dimeric form in the stock solution and
it is partially stabilized by intermolecular disulﬁde bridges; on the
other hand, the zinc-mediated effect at relatively high TPPP/p25 con-
centration is less pronounced since the major part of the disordered
protein is in dimeric form even in the absence of zinc.
Therefore, the in vitro data obtainedwith human recombinant TPPP/
p25 underline the crucial role of the divalent zinc cation in the forma-
tion/stabilization of the dimeric form which has been proposed to beexpression levels as determined by cELISA. A: TPPP/p25 expression was induced by doxy-
y column) or 10 (white column) μM ZnCl2 at different expression levels of TPPP/p25 was
s (SEM) (n= 3). * Signiﬁcant difference between samples with and without the addition
Fig. 5. Effect of inhibition of protein synthesis by cycloheximide (CI) on the zinc-induced
elevation of the intracellular TPPP/p25 level determined by immunoblotting (A) and
quantiﬁed by densitometry using ImageJ 1.42 (shown in B). Doxycycline induction
(Lane 5), CI treatment in the absence (Lane 1–2, from parallel samples) and presence of
zinc (Lane 3–4, from parallel samples). TPPP/p25 expression was induced by 100 ng/mL
doxycycline (overnight), then the cells were treated with 20 μg/mL CI and/or 10 μM
Zn2+ as described in the Materials and methods. GAPDH was used as loading control.
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neither the structural nor the functional effects induced by Zn2+ were
detected by other cations such as Ca2+ and Al3+ [29]. This issue is
now supported by control data obtained with Mn2+ in both TSQ and
sandwich ELISA experiments (cf. Fig. 1A and C).Fig. 6. Quantiﬁcation of the effect of Zn2+ on the intracellular TPPP/p25 level in CHO10
cells at different expression levels. The TPPP/p25 level was determined by cELISA as de-
scribed in the Materials and methods. The TPPP/p25 expression level was modulated
withMG132 (grey columns) or with cycloheximide block (CI, black columns) treatments.
TPPP/p25 expression was induced by 100 ng/mL doxycycline (overnight), then the cells
were treated with 20 μg/mL CI and/or 10 μM Zn2+ and/or 10 μMMG132 as described in
the Materials and methods. Error bars represent the standard error of the determinations
(SEM) (n=3). * Signiﬁcant difference between samples with and without the addition of
zinc and/or MG132 (according to Student's t-test, p b 0.05).3.4. Zinc-induced enhancement of the intracellular TPPP/p25 level
In order to visualize the zinc-induced alterations at cell level, the in-
tracellular TPPP/p25 concentration was analyzed in vivo with CHO10
and CG-4 cell lines expressing TPPP/p25 ectopically and endogenously,
respectively. While CHO10 cells express TPPP/p25 following doxycy-
cline induction, in the CG-4 oligodendrocyte cells TPPP/p25 is expressed
endogenously at low level in the progenitor cells and at high level in the
differentiated cells. The rational of these studies was based on our early
observation that the inhibition of the proteasomemachinery byMG132
elevated the TPPP/p25 level in HeLa cells [40]; it was concluded that the
intrinsically unstructured TPPP/p25 can be degraded by the proteasome
[40,41]. Thus wewere interested in how the zinc uptake from themedi-
um affects the intracellular TPPP/p25 level.
CHO10 cells were induced by doxycycline to express TPPP/p25 ec-
topically at modest level, then they were grown in medium without
or with 10 μM ZnCl2 (3 h) to analyze the effect of this short-term treat-
ment. The TPPP/p25 level (red) was visualized by confocal ﬂuorescence
microscopy using anti-TPPP/p25 antibody for speciﬁc staining. Fig. 2
presents a global overview of the effect of zinc-treatment that suggests
the elevation of total TPPP/p25 level.Next, we characterized the zinc-mediated effect on the intracellular
TPPP/p25 level at various circumstances which could occur at physio-
logical and/or pathological conditions.
The microtubule network is the major target of TPPP/p25: it speciﬁ-
cally co-localizes with the microtubule but not with the actin ﬁlament
[40] andmodulates its dynamics and stability by its acetylation enhanc-
ing and bundling activities [34]. To obtain information on the role of the
microtubule network in the zinc-induced elevation of the intracellular
TPPP/p25 level, CHO10 cells expressing TPPP/25 and uploaded by zinc
were treated with vinblastine, a well-established anti-microtubule
agent (Fig. 3A). In the case of the untreated cells (no zinc) the TPPP/
p25 level was considered as a control; the uptake of zinc cation resulted
in signiﬁcant enhancement in the intracellular TPPP/p25 level which
was aligned along the ﬁlamentous (microtubule) network. The vinblas-
tine treatment caused the collapse of the microtubule network in the
zinc-treated and untreated cells. However, the zinc-containing cells
apparentlymaintained higher TPPP/p25 level than the control ones like-
ly due to the zinc-induced structural changes, indicating the stabilizing
effect of this cation. These effects were quantiﬁed by cELISA as shown in
Fig. 3B. The data revealed that zinc increased the TPPP/p25 level in sim-
ilar extent independently of the disassembly of the microtubule net-
work, although the absolute concentration of TPPP/p25 was higher in
the control sample than in the vinblastine-treated one (it was less de-
graded); therefore the zinc can elevate the decoration of the microtu-
bule network by TPPP/p25.
Next, we studied how the intracellular expression level of TPPP/p25
inﬂuences the zinc-mediated stabilizing effect. In this set of experi-
ments TPPP/p25 was expressed in CHO10 cells at different levels in
the absence and presence of 5 or 10 μMZnCl2 (Fig. 4). cELISA assays pro-
vided quantitative data for the effect of zinc (Fig. 4B).We found that zinc
increased the TPPP/p25 level at all concentrations of doxycycline except
the highest. At 2500 ng/mL doxycycline induction the TPPP/p25 level
seems to reach the upper limit; thus it is not surprising that the zinc-
induced TPPP/p25 level is similar. This phenomenon could be attributed
to different regulatory mechanisms; some of them have been identiﬁed
Fig. 7. Effect of Zn2+ on the endogeneous expression of TPPP/p25 in living CG-4 cells. The images of the cells at two different ampliﬁcation are shown obtained by immunoﬂuorescence
microscopy using monoclonal anti-tubulin (green) and anti-TPPP/p25 (red) antibodies. The cells were treated with 1 μM Zn2+. Nuclei were counterstained with DAPI (blue). Scale bar:
12.5 μm (A) and 5 μm (B).
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degradation) [40,42].
In another set of experiments the protein synthesis was inhibited by
cycloheximide [43,44] in CHO cells expressing TPPP/p25 atmodest level
(cf. Fig. 4) and the effect of zinc treatment on TPPP/p25 level was deter-
mined. Fig. 5 shows that the level of TPPP/p25, but not of GAPDH, was
reduced signiﬁcantly, and the presence of zinc counteracted this reduc-
ing effect as detected by immunoblotting. Indeed, the addition of ZnCl2
to the cycloheximide-treated cells increased the intracellular TPPP/p25
level compared to the untreated ones. GAPDH, the synthesis of which
is not inhibited by cycloheximide during the incubation due to its rela-
tively long half-line [45], was used as loading control. These data (see
also Fig. 6 for cELISA) further conﬁrm that the positive effect of zinc
on the enhancement of the TPPP/p25 level manifests itself even at con-
dition when protein synthesis is inhibited.3.5. Zinc inhibits the proteasome-derived degradation of TPPP/p25
Our previous results proved that the inhibition of the proteasome
machinery by MG132 results in the elevation of TPPP/p25 level, and
suggest its degradation by the proteasome [40]. To further characterize
the inﬂuence of the zinc-induced structural changes in relation to the
proteasome-derived degradation of TPPP/p25, CHO10 cells expressing
TPPP/p25 were treated with MG132 and/or ZnCl2 in the absence and
presence of cycloheximide, and the TPPP/p25 level was quantiﬁed by
cELISA (Fig. 6). These data provided evidence that the Zn2+-induced
structural change can enhance the intracellular level of the disorderedprotein by inhibiting its proteasomal degradation. cELISA analysis ren-
dered it also possible to determine the combined effect of zinc and
MG132 and to compare it with the effect caused by MG132 alone.
Since these data did not differ signiﬁcantly, it can be concluded that
the zinc-induced structural change of TPPP/p25, including the dimeriza-
tion, protects the disordered protein against its proteolytic degradation
by the proteasomal machinery.
The physiological relevance of the zinc effect on the intracellular
level of TPPP/p25 was also tested in CG-4 cells expressing the disor-
dered protein endogeneously. As we have reported recently, the TPPP/
p25 level is very low in the dividing progenitor cells. However, in the
course of differentiation the TPPP/p25 level is drastically increasing;
the down-regulation of TPPP/p25 by siRNA or miR206 signiﬁcantly im-
peded the differentiation of the progenitor cells [22]. Fig. 7 shows that,
on one hand, TPPP/p25 is aligned along the microtubule network in
the projections; on the other hand, the presence of zinc can enhance
the intracellular TPPP/p25 level in progenitor cells which likely contrib-
ute to the extension of projections during the differentiation.4. Discussion
Zinc ion, the second most abundant trace element in the human
body, is essential for the structural stability of a variety of proteins
involved in transcription, protein trafﬁcking and enzymatic reactions [1,
2]. The intracellular free zinc concentration is usually in the nanomolar
range; however, oligodendrocyte progenitor cells accumulate Zn2+. In
myelinating oligodendrocytes, where TPPP/p25 is endogenously
90 A. Lehotzky et al. / Biochimica et Biophysica Acta 1852 (2015) 83–91expressed, the intracellular Zn2+ concentration has been found to be
relatively high (50 μM) [10,11]. In our experiments the concentrations
of the ZnCl2 added to the medium of CHO10 and oligodendrocyte CG-
4 cell lines for zinc uptake were 5–10 μM and 1–2 μM, respectively.
Therefore, the effect of this divalent cation appears to be physiologically
relevant as the plasma and CSF Zn2+ concentration (~10 μMand ~2 μM)
are comparable with these values, respectively [46]. Previously we re-
ported that TPPP/p25 is extensively expressed during thedifferentiation
of the progenitor cells which is crucial for the maturation of the oligo-
dendrocytes [22]. However, its lack or enrichment was detected in oli-
godendrocyte cells of human brain tissues in the cases of glioma and
multiple system atrophy, respectively [24,25]. Now we established
that the zinc uptake by progenitor oligodendrocytes gently modiﬁes
the TPPP/p25 level coupled with an enhancement of decoration of the
microtubule network which could contribute to the initiation of differ-
entiation. The decoration of the microtubule network by TPPP/p25
with its bundling and acetylation enhancing activities resulting in the
stabilization of the network is a signiﬁcant factor in aggresome forma-
tion [34]. These results suggest that the structural rearrangement of
TPPP/p25 caused by zinc binding to the zincﬁngermotive could be a po-
tential factor in brain physiology to optimize the intracellular TPPP/p25
level according to its physiological function.
A couple of unfolded/misfolded proteins due to their extensive
aggregation-prone features are involved in distinct neurological and
other disorders; for example tau/β-amyloid and α-synuclein are
hallmark proteins of Alzheimer's and Parkinson's diseases, respectively
[47–49]. There are intracellular mechanisms which could eliminate
these “unwanted” proteins such as the proteasoma machinery [50–52].
We established that the proteasomal degradation is themajor, if not ex-
clusive, system responsible for the elimination of the disordered TPPP/
p25. The degradation of TPPP/p25 is inhibited by MG132, a well-
established inhibitor of proteasome [50]. The stabilization of TPPP/p25
against the proteolytic degradation is resulted from the structural chang-
es of this disordered protein coupled with dimerization which is essen-
tial for the extension of projections playing a role in the maintenance
of the stability of the myelin sheath in the CNS. Thus, we suggest that
the zinc, as a speciﬁc divalent cation could be involved in the ﬁne-
tuning of the physiological TPPP/p25 level. This is an important issue
since both the enrichment and the lack of this protein lead to CNS dis-
eases such asmultiple system atrophy [25] and glioma [24], respectively.
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